VP, Head of Drug Substance Development

Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.

It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.

Led by Tassos Giannakakos, Jay Edelberg, M.D. and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading Myo Kardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.

We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.

At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals.
Driven by patients and their families
, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic
—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn
, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.

These values are the foundation of our work, empowering us to make a real difference, every day.

Location:

South San Francisco, CA or Princeton, NJ (preferred)

Onsite: 4 days/week

Kardigan is seeking an accomplished and forward‑thinking, highly effective leader to serve as Vice President, Head of CMC Drug Substance Development. Reporting directly to the Chief Technical Operations Officer, this leader will build and oversee a best-in-class Chemical Development organization supporting a growing early‑stage pipeline and a complex late‑stage portfolio across small molecules and oligonucleotides.

This role is responsible for end‑to‑end API development — from route design through commercial readiness — and for providing technical, strategic, and operational leadership across all internal and outsourced development and manufacturing activities.

• Provide strong, visible leadership to the Chemical Development function.
• Build, lead, mentor, and retain a high‑performing team supporting programs from early development through commercialization.
• Oversee onboarding, career development, and capability building across the organization.
• Foster a culture of scientific excellence, accountability, and collaborative problem‑solving.
• Build a culture within Chem Dev that collaborates well and works effectively with others.
• Support the ongoing development and growth of the Tech Ops capability within Kardigan, contribute effectively as a member of the Tech Ops LT.

• Lead route selection, process optimization, scale‑up, technology transfer, validation, and manufacturing strategy for all drug substance programs.
• Ensure processes are designed to meet quality, yield, cost, and scalability targets appropriate for each development stage.
• Develop and manage phase‑appropriate plans for process development, manufacturing, and supply.
• Oversee and provide technical governance for all CDMO/CMO‑executed activities.

• Batch release activities group.
• Establish drug substance specifications and stability programs in partnership with Analytical, Quality, and Regulatory functions.
• Author and review CMC documentation for regulatory submissions, including protocols, reports, and Module 3 sections.
• Support investigations, deviations, and root‑cause analyses to ensure robust scientific and operational outcomes.

• Partner closely with Drug Product, Analytical Development, Regulatory Affairs, Quality…